Imagery Rescripting as a Stand-alone Treatment for OCD and BDD.

Recruiting now · Not applicable

Conditions studied: Obsessive-Compulsive Disorder, Body Dysmorphic Disorders, Anxiety Disorders

In brief

The goal of this multiple baseline case series study is to test the effect of imagery rescripting (ImRs) in Obsessive Compulsive Disorder (OCD) and Body Dysmorphic Disorder (BDD). Primary objective :The course of schema or core beliefs and change in OCD and BDD. To investigate the effectiveness of imagery rescripting on factors presumed to underlie the disorder, according to schema theory, and on OCD and BDD symptoms. Secondary objective: The change in OCD and BDD symptoms (full questionnaire), schemata and modes, core emotions, mood, affect and obtrusiveness of intrusion. Other objectives are research into the working mechanisms of imagery rescripting by collecting qualitative data from patients and their practitioner in a qualitative interview. For this study, a multiple-baseline single-case experimental design (SCED) is used testing different outcome variables in 18 OCD patients and 18 BDD patients. After a variable baseline period of 3-8 weeks participants will start twice weekly with imagery rescripting for 12 sessions, followed by a 6 week follow up. Participants will rate schema- or core beliefs and OCD or BDD severity on a visual analogue scale. In addition participants will rate core emotions, affect and obtrusiveness of the intrusion. Secondary we will asses four times questionnaires about OCD of BDD symptoms, depression and schemas en modes. After treatment participants will be interviewed about their experiences.

Key facts

Study ID

NCT06346301

Run by

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

People needed

36

Starts

2023-04-21

Expected to finish

2027-01-01

Last updated by the study team

2024-04-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meet the criteria for OCD or BDD, a primary diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
• Are aged 18 and beyond
• Dutch literacy
• Cut-off Y-BOCS of 20
• No change in medication. Stable dose at least 6 weeks prior to study.

You may not qualify if…

• Current (hypo)mania
• Active suicidal plans
• Current psychosis (excluding delusional symptoms related to disorder)
• Alcohol or drugs abuse as diagnosed by Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
• Electroconvulsive therapy in last 6 months
• Neurological disorder or Intelligence Quotient < 80

Where it is running

• Department of Psychiatry, AMC — Amsterdam-Zuidoost, North Holland, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.